Protalix BiotherapeuticsPLX
13F holders, Q1 2025 (March 31)63holders +18
23new positions
5sold out
3famous investors
$2.56avg. 13F price*
At the end of Q1 2025, 63 institutions reported holding Protalix Biotherapeutics Inc. (PLX) in their 13F filings, up 18 from Q4 2024. 23 opened new positions and 5 sold out. The largest holders were Renaissance Technologies ($3.0M), Millennium Management ($2.5M) and Susquehanna International Group, LLP ($2.2M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Protalix Biotherapeutics Inc.
- CUSIP
- 74365A309
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 23 | $6.1M |
| Exits | 5 | $140K |
All 13F filers, Q4 2024 → Q1 2025: 4,313,115 shares bought and 522,360 shares sold, net +3,790,755 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 63 holders
| Renaissance Technologies | 0.00% | Add +6.3% | 1,188,953 | $3.0M |
| Millennium Management | 0.00% | Add +148.3% | 963,011 | $2.5M |
| Susquehanna International Group, LLP | 0.00% | New | 858,650 | $2.2M |
| Northern Trust Corp. | 0.00% | Reduce -6.4% | 684,758 | $1.8M |
| Marshall Wace, LLP | 0.00% | Add +503.6% | 615,085 | $1.6M |
| Connor, Clark & Lunn Investment Management Ltd. | 0.01% | New | 482,875 | $1.2M |
| Stratos Wealth Partners, LTD. | 0.01% | Add +28.3% | 346,400 | $887K |
| Jane Street Group, LLC | 0.00% | Add +159.1% | 294,318 | $753K |
| Goldman Sachs Group Inc. | 0.00% | Add +482.3% | 289,461 | $741K |
| BlackRock, Inc. | 0.00% | Add +13.3% | 254,535 | $652K |
| Gsa Capital Partners LLP | 0.05% | Reduce -31.6% | 209,292 | $536K |
| Bridgeway Capital Management, LLC | 0.01% | Add +4.2% | 189,100 | $484K |
| OMERS ADMINISTRATION Corp | 0.00% | New | 179,300 | $459K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 163,058 | $417K |
| Squarepoint Ops LLC | 0.00% | Add +63.4% | 120,786 | $309K |
| Qube Research & Technologies Ltd | 0.00% | Add +377.8% | 118,808 | $304K |
| Hillsdale Investment Management Inc. | 0.02% | New | 116,100 | $297K |
| Two Sigma Investments, LP | 0.00% | New | 86,354 | $221K |
| Morgan Stanley | 0.00% | Reduce -50.9% | 83,558 | $214K |
| Jain Global LLC | 0.00% | New | 81,963 | $210K |
| Balyasny Asset Management L.P. | 0.00% | New | 76,063 | $195K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.04% | Add +1.3% | 54,174 | $139K |
| Cubist Systematic Strategies, LLC | 0.00% | Add +82.1% | 53,380 | $137K |
| Quantessence Capital LLC | 0.03% | New | 51,243 | $131K |
| Commonwealth Equity Services, LLC | 0.00% | Add +0.1% | 50,025 | $128K |
| Orin Green Financial, LLC | 0.06% | New | 50,000 | $128K |
| LMR Partners LLP | 0.00% | New | 49,025 | $126K |
| Kestra Advisory Services, LLC | 0.00% | Add +217.9% | 44,500 | $114K |
| XTX Topco Ltd | 0.01% | New | 41,826 | $107K |
| Prudential Financial Inc. | 0.00% | No change | 36,400 | $93K |
| Two Sigma Advisers, LP | 0.00% | New | 33,015 | $85K |
| Creative Planning | 0.00% | New | 32,740 | $84K |
| Catalyst Funds Management Pty Ltd | 0.02% | Add +166.1% | 27,139 | $69K |
| Earned Wealth Advisors, LLC | 0.01% | No change | 25,976 | $66K |
| HSBC Holdings PLC | 0.00% | Reduce -36.2% | 25,535 | $64K |
| Barclays PLC | 0.00% | Reduce -29.2% | 24,310 | $62K |
| Aptus Capital Advisors, LLC | 0.00% | Add +2.5% | 23,938 | $61K |
| Capula Management Ltd | 0.00% | New | 15,690 | $40K |
| Lido Advisors, LLC | 0.00% | No change | 15,554 | $40K |
| Capstone Investment Advisors, LLC | 0.00% | New | 15,336 | $39K |
| Raymond James Financial Inc. | 0.00% | New | 15,174 | $39K |
| NewEdge Advisors, LLC | 0.00% | New | 15,080 | $39K |
| Brevan Howard Capital Management LP | 0.00% | New | 13,474 | $34K |
| Altshuler Shaham Ltd | 0.00% | No change | 12,142 | $31K |
| Hudson Bay Capital Management LP | 0.00% | New | 12,000 | $31K |
| Harbour Investment Management LLC | 0.01% | No change | 10,100 | $26K |
| Acadian Asset Management LLC | 0.00% | New | 9,691 | $24K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 6,000 | $15K |
| Point72 (DIFC) Ltd | 0.00% | Add +524.1% | 5,623 | $14K |
| Citadel Advisors | 0.00% | Reduce -98.1% | 2,818 | $7K |
| Truvestments Capital LLC | 0.00% | No change | 2,458 | $6K |
| Citigroup Inc. | 0.00% | Add +262.7% | 2,292 | $6K |
| UBS Group AG | 0.00% | Reduce -88.5% | 2,087 | $5K |
| JPMorgan Chase & Co. | 0.00% | No change | 1,595 | $4K |
| Lazard Asset Management LLC | 0.00% | Reduce -36.5% | 797 | $2K |
| BNP Paribas Financial Markets | 0.00% | Reduce -2.1% | 701 | $2K |
| Investment Research & Advisory Group, Inc. | 0.00% | New | 600 | $2K |
| Osaic Holdings, Inc. | 0.00% | Add +100.0% | 400 | $1K |
| Activest Wealth Management | 0.00% | No change | 300 | $768 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 250 | $640 |
| Y.D. More Investments Ltd | 0.00% | No change | 220 | $563 |
| SBI Securities Co., Ltd. | 0.00% | New | 50 | $128 |
| Bank of America Corp. | 0.00% | Reduce -100.0% | 6 | $16 |
"% of holder's portfolio" is PLX's weight in each manager's 13F, not the share of Protalix Biotherapeutics Inc. the manager owns.